Targeting a MicroRNA Shows Potential to Enhance Effectiveness of Diabetes Drugs


 

Over the past 15 years, UAB endocrinologist Anath Shalev, MD has unraveled a crucial biological pathway that malfunctions in diabetes.

Her latest discovery in this beta-cell pathway, published in the journal Diabetes, shows the potential to enhance the effectiveness of existing diabetes drugs.

In 2013, the UAB researchers found that either diabetes or elevated production of the protein TXNIP induced beta-cell expression of microRNA-204, or miR-204, and this microRNA, in turn, blocked insulin production.

The Shalev group has now found another vital role for miR-204 -- regulating the cell surface receptor that is the target of many of the newer type 2 diabetes drugs. This drug target is the glucagon-like peptide 1 receptor, or GLP1R. Activation of GLP1R with these drugs helps the beta cell produce and secrete more insulin.

Shalev's new work was performed in rat beta cells, genetically modified mice, mouse pancreatic islets and human pancreatic islets. Healthy beta cells, which are found in the pancreatic islets, produce insulin to control blood sugar levels; in diabetes the beta cells are impaired and dysfunctional, and have lower GLP1R levels.

Shalev and colleagues found that overexpression of miR-204 decreased expression of GLP1R in rat beta cells and in mouse and human pancreatic islets. Conversely, knock-down of miR-204 increased expression of GLP1R in those cells and pancreatic islets.

Greater GLP1R expression is beneficial because it helps transfer a signal to the beta cell to secrete more insulin, such as after a meal. Also, many of the newer diabetes drugs act as agonists to activate GLP1R. Higher expression can allow use of a lower-drug dose to treat diabetes, thus reducing dose-dependent side effects.

In mice, the UAB researchers found that a deletion of miR-204 caused enhanced GLP1R expression, and also better insulin secretion and glucose control. Furthermore, the knockout mice were more responsive to a GLP1R agonist in glucose tolerance tests. When the GLP1R knockout mice were used in a model of diabetes, where beta cells are damaged by low doses of the toxin streptozotocin, the diabetic mice showed improved glucose control and increased serum insulin levels.

These results suggest that downregulating miR-204, now revealed as an upstream regulator of GLP1R, could lead to better treatment of diabetes.

 
Share:

 

More Grand Rounds:

 

Women's Care Specialists Moving Practice

Women's Care Specialists Moving Practice

Women's Care Specialists is moving its practice to the Physicians Plaza at Grandview Medical Center this coming fall.

Read More

Moul Joins Birmingham Orthopedics & Spine Specialists

Moul Joins Birmingham Orthopedics & Spine Specialists

Rebecca Moul, DO has joined Birmingham Orthopedics & Spine Specialists. Moul is board certified by the AOBOS. She specializes in orthopedic surgery, Arthroscopy and sports medicine.

Read More

Fayette Medical Center and its Long Term Care Facility among Top in US

FMC achieved a five-star rating from the Center for Medicare and Medicaid Services.

Read More

Number of Premature Babies Born to Single Mothers Decreases Thanks to Partnership

The number of premature births in Jefferson County has decreased thanks to the Nurse-Family Partnership, a program run by the University of Alabama at Birmingham School of Nursing and the Jefferson County Department of Health.

Read More

Grandview Names Employee of the Year

Grandview Names Employee of the Year

Trussville resident Hai Nguyen was recently named Grandview Medical Center's 2018 Employee of the Year.

Read More

BCBS Promotes Williams

BCBS Promotes Williams

Blue Cross and Blue Shield of Alabama has promoted Tyler Williams to Vice President, District and Consumer Sales.

Read More

Butler Named Dean of UAB School of Health Professions

Butler Named Dean of UAB School of Health Professions

The University of Alabama at Birmingham has named Andrew J. Butler, MPT, MBA, PhD, dean of the UAB School of Health Professions following a national search.

Read More

Bogard to Chair Health Law Section of Alabama State Bar

Bogard to Chair Health Law Section of Alabama State Bar

Howard Bogard, a partner with Burr Forman, was recently appointed to serve as chair of the Alabama State Bar Association's (ASB) Health Law Section.

Read More

North Harbor Pavilion Recognized

North Harbor Pavilion at Northport Medical Center has been recognized for providing outstanding patient experience.

Read More

Hindman Named CNO at Princeton

Hindman Named CNO at Princeton

Robbie Hindman has been named Chief Nursing Officer (CNO) of Princeton Baptist Medical Center.

Read More

UAB Graduate Programs Ranked among Nation's best

Master's in Health Administration Ranked No. 1

Read More

Luther Joins Grandview Medical Staff

Luther Joins Grandview Medical Staff

Michael Luther, MD has joined the medical staff of Grandview Medical Center. Luther is board certified in Family Medicine. He is in practice with Grandview Medical Group Primary Care in Homewood.

Read More

Georgiana Medical Center Will Close

Georgiana Medical Center, located in Greenville, Alabama, will close its doors on March 31. The hospital's operator, Ivy Creek of Butler, says patient care will be directed to L.V. Stabler Memorial Hospital in Greenville, as well as to other providers.

Read More

NIH Funding to UAB Near $300 million

Research funding to UAB from the National Institutes of Health came in just shy of $300 million in 2018, placing UAB 23rd on the list of universities receiving NIH funding, according to figures published by the Blue Ridge Institute for Medical Research.

Read More

Allen Jarzombek, MD Joins Grandview Medical Staff

Allen Jarzombek, MD Joins Grandview Medical Staff

Allen Jarzombek, MD has joined the medical staff of Grandview Medical Center. Jarzombek is board certified in Family Medicine and practices with Grandview Medical Group Primary Care in Chelsea.

Read More

Donaldson Named CFO at Cullman Regional

Donaldson Named CFO at Cullman Regional

Cullman Regional has named Nesha Donaldson, FACHE, as Chief Operations Officer, a role she has filled in conjunction with her Chief Financial Officer position for more than a year.

Read More

Jade Brice Roshell, MD, MBA, FHM, FACP Named Chief Medical Officer of Shelby Baptist

Jade Brice Roshell, MD, MBA, FHM, FACP Named Chief Medical Officer of Shelby Baptist

Jade Brice Roshell, MD, MBA, FHM, FACP, who serves as Director of the Shelby Baptist Medical Center Hospitalist Program has been named Chief Medical Officer (CMO).

Read More

Jacobsmeyer and Rock Named Go Red for Women Co-Chairs

Jacobsmeyer and Rock Named Go Red for Women Co-Chairs

Barbara Jacobsmeyer and Dawn Rock are the co-chairs of the American Heart Association's 2019 Birmingham Go Red for Women campaign.

Read More

Children's to Provide At-Home Monitoring

Parents of infants with complex heart defects will now be given a new telehealth platform when they are discharged from Children's of Alabama to monitor the home recovery process.

Read More

Two Brookwood Baptist Health Officers Named to Becker's 2019 List of African American Leaders

Becker's Hospital Review has published its 2019 list of 68 African American Leaders in Healthcare. The list highlights African Americans who have taken on healthcare leadership roles across the country.

Read More

 

Email Print
 

Tags:
None
220km.com.ua

вода на дом

ua-flowers.com/
Powered by

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: